dose escalation trial

Related by string. * Doses . DOSE . DO Se . DOSES : mg kg dose . tolerated dose MTD . multiple ascending dose . priming doses / escalations . Escalation . Escalations . ESCALATION : label dose escalation . dose escalation study . dose escalation . dose escalation clinical / trialed . trialing . trials . Trial : Phase III clinical trials . Week Premium Trial . Phase III trials . randomized controlled trial * *

Related by context. Frequent words. (Click for all words.) 80 dose escalation study 77 Phase 1b 76 Phase 2b trial 76 Phase Ib 76 Phase 2b study 74 dose escalation 74 Phase 2a clinical 73 randomized Phase 72 pivotal Phase III 71 Phase IIa trial 71 Phase IIa clinical 71 Phase IIb 71 Phase III clinical 71 pivotal Phase 71 Phase IIa 71 Phase 2a 70 Phase 2b clinical 70 randomized placebo controlled 70 placebo controlled 69 double blind placebo 69 Phase 2b 69 blind randomized placebo 69 Phase IIb clinical 69 Phase IIb trial 68 randomized double 68 Phase III 67 clinical trial 67 safety tolerability 66 randomized controlled 66 tolerability 66 IMGN# 65 Phase II 65 blind randomized 65 pharmacodynamics 65 prospective randomized 64 ofatumumab 64 multicenter 64 Phase III clinical trials 64 blind placebo controlled 64 RG# [001] 63 pharmacokinetic profile 63 Phase 63 randomized clinical 62 pharmacokinetic 62 randomized 62 perifosine 62 dosing regimens 61 AP# [003] 61 evaluable patients 61 INCB# [002] 61 Phase III trials 61 XL# [003] 60 CYT# 60 initiate Phase 60 monotherapy 60 mg dose 60 LEVADEX 59 docetaxel 59 temozolomide 59 pharmacokinetics 59 MGCD# [001] 59 carfilzomib 59 multicenter study 59 unblinded 59 antitumor activity 59 relapsing remitting multiple sclerosis 59 investigational compound 59 dose regimen 59 RDEA# 59 immunogenicity 59 FOLOTYN 59 eculizumab 59 T DM1 59 TMC# [001] 59 sunitinib 58 gemcitabine 58 lubiprostone 58 pralatrexate 58 antiviral activity 58 ISIS # 58 IDX# 58 clinical trials 58 tolerability profile 58 mg/m2 58 humanized monoclonal antibody 58 efficacy 58 Clinical Study 58 investigational drug 57 CRx 57 PRX # 57 HspE7 57 Alpharadin 57 JANUVIA 57 Clolar 57 ACTEMRA 57 non inferiority 57 cutaneous T cell 57 DSMB 57 sorafenib 57 pharmacodynamic 57 MDV#

Back to home page